Dossier · TBI · Dormant
TBI · Trueblue, Inc. · Stock research
Last analysed ·
Resolved Graded and closed 2026-08-05 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-08-16 and is not part of the scored record.
Current thesis
Deep-cyclical industrial staffer re-rated +140% off the $3.18 low on a staffing-demand recovery and a data-center/energy labor boom lifting PeopleReady +19% YoY. Still loss-making (Q1 net -$19.8M), margins compressed, and the industrial-staffing index has cooled from +10% to +2% YoY. The 2026-08-04 Q2 print is the profitability-inflection binary.
Kill line
A weekly close below $6.50 forfeits the recovery leg off the $3.18 low; further confirmed if the 2026-08-04 Q2 print delivers another adjusted-EBITDA loss with gross margin missing the guided 21.1%–21.5%, or the industrial-staffing index turns negative YoY.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for TBI —
As of 16 August 2026, the latest FrontierPicks analysis for Trueblue, Inc. (TBI): Deep-cyclical industrial staffer re-rated +140% off the $3.18 low on a staffing-demand recovery and a data-center/energy labor boom lifting PeopleReady +19% YoY. Still loss-making (Q1 net -$19.8M), margins compressed, and the industrial-staffing index has cooled from +10% to +2% YoY. The 2026-08-04 Q2 print is the profitability-inflection binary.
Kill line: A weekly close below $6.50 forfeits the recovery leg off the $3.18 low; further confirmed if the 2026-08-04 Q2 print delivers another adjusted-EBITDA loss with gross margin missing the guided 21.1%–21.5%, or the industrial-staffing index turns negative YoY.
Next dated event on file: — catalyst in 9d.
Current Thesis
The profitability binary flagged in the prior note resolved to the upside. TrueBlue reported Q2 2026 after the close on 2026-08-04: revenue $443.0M against a $417.8M consensus, adjusted EPS $0.06 against a $(0.10) estimate, and adjusted EBITDA of $11.4M versus $2.6M a year earlier. Q3 revenue was guided to $461–481M, above the $454.1M consensus. The stock closed the regular session that day at $7.69 (Investing.com) and printed a $10.23 reference close on 2026-08-14, a +81.1% three-month return with RSI(14) at 73.2.
The narrative leg on offer: a legacy blue-collar staffer whose largest segment has been re-pointed at data-center and energy construction labor, and which has now shown that the volume converts to segment profit — PeopleReady revenue $262M (+23% YoY), segment profit +460% to $9M, segment margin 3.3% (+260 bps). The half that did not resolve is margin. Gross margin came in at 20.7% versus 23.6% a year earlier, below the 21.1%–21.5% management guided alongside Q1 in May, and Q3 is guided to 20.4%–20.8% — no sequential recovery embedded. Life-cycle read is accelerating, dated by the 2026-08-04 beat, Baird's 2026-08-06 target raise, and momentum coverage on 2026-08-11. The entry arithmetic is the least attractive part: $10.23 sits above every published target.
Bullish and bearish views on Trueblue, Inc.
The model's bull view on Trueblue, Inc. (TBI), in brief: Q2 2026 (reported 2026-08-04): revenue $443.0M vs $417.8M consensus; adjusted EPS $0.06 vs a $(0.10) estimate — the first clean beat of the recovery leg. The bear view: Gross margin 20.7% in Q2, down 290 bps YoY, and below the 21.1%–21.5% guided with Q1. Both cases follow in full.
Bull Case
- Q2 2026 (reported 2026-08-04): revenue $443.0M vs $417.8M consensus; adjusted EPS $0.06 vs a $(0.10) estimate — the first clean beat of the recovery leg.
- Adjusted EBITDA $11.4M vs $2.6M in Q2 2025; adjusted EBITDA margin 2.6%, +190 bps YoY. The operating leverage the turnaround was priced on showed up in one quarter.
- PeopleReady $262M, +23% YoY, with the energy vertical roughly doubling and the core on-demand book returning to growth (Q2 2026 earnings presentation, 2026-08-04).
- Q3 guide $461–481M (+7% to +11% YoY) against a $454.1M consensus; PeopleReady guided +11% to +15%, PeopleManagement +3% to +8%.
- SG&A $84M in Q2, down 7% from $90M, with Q3 guided $85–89M (-7% to -3% YoY) — the cost line is still being taken out while revenue accelerates.
- Baird raised its target to $9.50 from $7.00 on 2026-08-06; the coverage set is 3 firms (1 Strong Buy, 2 Hold) as of 2026-08-11, so estimate revisions have room to run from a low base.
Bear Case
- Gross margin 20.7% in Q2, down 290 bps YoY, and below the 21.1%–21.5% guided with Q1. The margin condition named in the prior note actually failed; the equity was paid on volume instead.
- Q3 gross margin is guided 20.4%–20.8% — the midpoint is beneath the Q2 actual. Management is not underwriting a margin recovery in the current quarter.
- Growth is concentrated in one vertical. PeopleManagement was flat at $134M and PeopleSolutions fell 5% to $47M in Q2; the entire delta came from PeopleReady's energy exposure.
- The growth is consuming cash: total debt $82M at Q2 against $74M at Q1, cash $23M vs $24M, working capital up $22M in the quarter, $56M unused credit capacity remaining.
- Price sits above published fair-value work: the highest target in the coverage set is $10.00 and Morningstar's fair value was $7.59 as of 2026-08-11, against a $10.23 close on 2026-08-14.
- The macro input the prior note tracked has not been re-confirmed: the industrial-staffing index decelerated from +10% YoY in May to +2% in mid-June. A single quarter of company outperformance does not settle the cycle.
Setup & Price Structure
- Reference close $10.23 on 2026-08-14; 52-week high $10.60 on the adjusted series, -3.5% below it. Three-month return +81.1%.
- RSI(14) 73.2 as of 2026-08-14 — overbought and staying there through the post-print run.
- The 50-day moving average stood at $7.64 on 2026-08-11 while the stock traded $10.13 the same day (Barchart data published via Yahoo Finance). The distance between spot and a rising 50-day is unusually wide.
- The 2026-08-04 print moved the stock from a $7.69 regular-session close to $8.24 after hours. That reaction shelf, roughly $8.20–$8.30, is the structure the re-rate stands on; below it the print is fully round-tripped.
- Crowding/positioning observables (state, not verdict): short interest 2.91% of float with 2.67 days to cover (2026-08-11) — thin squeeze fuel; momentum-framed coverage clustered on 2026-08-11 around a new two-year high; every published target ($9.50 Baird, $10.00 high estimate) is at or below the last close; market cap ~$311M on a 60-month beta of 1.60.
- Insider record: director Sonita Lontoh sold 2,186 shares at a weighted average $6.73 on 2026-06-05, retaining 72,733 shares — pre-print, small against the holding, and the only recent Form 4 surfaced. No post-print insider sale has appeared in the filing record reviewed.
- No company-scheduled event falls in the next 30 days, which removes the near-term mechanism for a fresh leg.
Catalyst Calendar (next 30 days)
- 2026-09-04 — BLS Employment Situation for August (08:30 ET). Temporary-help services payrolls are the highest-frequency public read on the demand behind PeopleReady's on-demand book.
- ~2026-09-14 (est.) — monthly staffing-industry index updates. The prior reading path (+10% YoY in May to +2% in mid-June) is the cyclical input that the +23% PeopleReady quarter has to be reconciled against.
- ~2026-11-03 (est.) — Q3 2026 results. Outside the window, and the absence of a company catalyst before then is itself a structural fact for a name up 81% in three months.
What Would Change Our Mind
The margin line is where the case is thinnest. Management guided 21.1%–21.5% in May and delivered 20.7%; a Q3 gross margin under the guided 20.4% while revenue lands inside $461–481M would say the volume is being bought with price and the EBITDA slope flattens from here. A PeopleReady print below the guided +11% growth floor would remove the only accelerating segment.
On structure, a weekly close below $8.20 fills the 2026-08-04 earnings gap and forfeits the post-print re-rate; the rising 50-day near $7.64 (2026-08-11) is the deeper line and would put price back into the pre-print range. Balance-sheet deterioration — debt above the Q2 $82M with unused capacity below $56M — would change the quality of the growth even if revenue holds.
What would strengthen the case instead: a covering firm publishing a target above $10.50, a Q3 gross margin at or above 20.8%, or an August temporary-help payrolls print that turns positive month-over-month on 2026-09-04.
Correlation Notes
- The Q2 beat was carried by energy/data-center construction labor, so the name tracks the electrical and mechanical contracting and grid-buildout complex more closely than it tracks the general staffing cycle right now.
- Staffing comparables (ManpowerGroup, Robert Half, ASGN, Korn Ferry) share the macro-labor factor but not the vertical mix; a divergence between TBI and that group is the signature of the data-center labor story doing the work.
- Macro sensitivity runs through the monthly BLS temporary-help series and through data-center capex commentary from hyperscalers, one step removed.
- Small-cap mechanics: ~$311M market cap, 60-month beta 1.60, 3-firm coverage. Small-cap value flow and single-note target revisions move this more than they move a mid-cap peer.
Notes
- Analyst coverage is 3 firms (1 Strong Buy, 2 Hold) as of 2026-08-11; a single note re-prices the whole consensus target range.
- GAAP profitability is not established — the beat is on an adjusted line; Q1 2026 GAAP net loss was -$19.8M (-$0.66/diluted sh).
- An older 'Managed care & health services' tag on this name is a mis-classification; TBI is industrial/blue-collar staffing (PeopleReady, PeopleManagement, PeopleSolutions).
- Short interest 2.91% of float, 2.67 days to cover (2026-08-11) — the move is not squeeze-structured.
- Market cap ~$311M with 60-month beta 1.60: gap risk in both directions around company and macro labor prints.
Related · shared themes
HUM
Humana Inc.
Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.
OKTA
Okta, Inc.
Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme accelerating, this leg maturing; open risk is paying up for a stretched 52-week-high tape.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
ATEX
Anterix Inc.
The 2026-08-21 reclaim at $93.25 gave back to $90.38 on 2026-08-24 with RSI(14) at 29.8, the $88.20 shelf still holding on closes. No spectrum sale agreement announced in the 126 days since 2026-04-21 and no company item filed since 2026-08-11; the ~2026-08-26 FINRA print for the 2026-08-14 settlement is the only dated read inside 30 days besides the 2026-09-21 buyback expiry.
See also · stocks to watch